Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 05-1995 | 02-1995 | 11-1994 | 05-1994 | 02-1994 | |
| Gross Profit | 1,372 | 1,088 | 1,090 | 1,028 | 459 |
| Operating Expenses | 10 | 7 | 10 | 11 | 12 |
| Operating Income | -10 | -7 | -10 | -11 | -12 |
| Pre-tax Income | -10 | -7 | -10 | -11 | -12 |
| Net Income Continuous | -10 | -7 | -10 | -11 | -12 |
| Net Income | $-10 | $-7 | $-10 | $-11 | $-12 |
| EBITDA(a) | $-10 | $-7 | $-10 | $-11 | $-12 |